This inventor holds 3 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 6 EPO patents. Top assignee: Sekisui Medical Co., Ltd.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: Innovations by Yasushi Nakamura
Introduction
Yasushi Nakamura is a notable inventor based in Ryugasaki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the development of assays for various biomarkers. With a total of three patents to his name, Nakamura's work has the potential to enhance the accuracy and efficiency of medical testing.
Latest Patents
Nakamura's latest patents include a method for a prostate-specific antigen (PSA) assay and a reagent therefor. This innovative method allows for a simple and highly accurate assay of PSA through a one-step reaction that does not require carriers with varying average grain sizes. The PSA assay method involves sensitizing insoluble carriers of uniform average grain size, utilizing two types of anti-PSA monoclonal antibodies that react with both free PSA and PSA-ACT. Additionally, he has developed an insulin-specific assay that employs an antibody capable of sensitively and specifically detecting insulin, while remaining unaffected by proinsulin and insulin analogs.
Career Highlights
Nakamura is currently associated with Sekisui Medical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating more reliable diagnostic tools that can significantly impact patient care.
Collaborations
One of his notable collaborators is Tomo Shimizu, with whom he has worked closely on various projects aimed at improving assay technologies.
Conclusion
Yasushi Nakamura's contributions to medical diagnostics through his innovative patents demonstrate his commitment to enhancing healthcare solutions. His work continues to pave the way for advancements in the field, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
